Vyndaqel 20 MG capsule UD 120S
Ended Awarded
- Contract number
- SPE2DB25FWK27
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,847
Award facts
- Contract value 100% obligated
- $13,846.97 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,846.97 to AmerisourceBergen Drug Corp for the supply of Vyndaqel 20 mg capsule unit dose packages (120 count) with a firm fixed price structure. This non-set-aside delivery order, awarded on July 14, 2025, carries an ultimate completion date of August 4, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. Vyndaqel is a prescription pharmaceutical used to treat transthyretin (ATTR) amyloidosis, indicating this delivery order supports the medical supply requirements of the Department of Defense or related federal healthcare systems.
This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999 through December 2026. This prime pharmaceutical vendor contract serves as a comprehensive global supply vehicle enabling AmerisourceBergen Drug Corp to deliver pharmaceuticals, medical supplies, and specialty medications across multiple therapeutic domains to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated capability to meet federal procurement requirements through competitive awards and maintains an extensive portfolio of medical product deliveries supporting Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FWK27?
SPE2DB25FWK27 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 14, 2025.
How much is contract SPE2DB25FWK27 worth?
The government has obligated $13,847 on SPE2DB25FWK27.
Is contract SPE2DB25FWK27 an order under another contract?
Yes. SPE2DB25FWK27 is a delivery order under SPE2DB22D3501, an indefinite delivery contract.
Was contract SPE2DB25FWK27 competed?
The extent of competition for SPE2DB25FWK27 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award